Standard Biotools (LAB) Preferred Stock Liabilities (2022 - 2023)

Standard Biotools (LAB) has 2 years of Preferred Stock Liabilities data on file, last reported at $311.3 million in Q4 2023.

• On a quarterly basis, Preferred Stock Liabilities changed 0.0% year-over-year to $311.3 million in Q4 2023; TTM through Dec 2023 was $311.3 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $311.3 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities for Q4 2023 stood at $311.3 million, roughly flat from $311.3 million in the prior quarter.
• Over the last five years, Preferred Stock Liabilities for LAB reached as high as $311.3 million in Q2 2022 and fell as low as $311.3 million in Q2 2022.